4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-25-013404
EVP, Chief Commercial Officer sold 4,002 shares at $36.68 ($146,793)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Callos Andrew · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-05 | Sale : show line 1 in the form 10b5-1 | −4,002 | $36.68 | $146,793 | 60,687 | D |
| Open-market sales · 4,002 sh · avg $36.68 · $146,793 | ||||||
Loading xslF345X05/form4.xml…